- Investing Ideas
- /
- Global Undervalued Solid Performers
Global Undervalued Solid Performers
UPDATED May 18, 2024
Companies meeting several financial criteria and filtered from the entire market.
250 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
2330 | NT$835.00 | 4.1% | 57.0% | NT$21.7t | NT$919.13 | PE25.3x | E16.3% | 1.9% | Semiconductors | ||
COST | US$795.81 | 1.1% | 60.3% | US$352.9b | US$780.30 | PE51.9x | E7.5% | 0.6% | Consumer Retailing | ||
600519 | CN¥1,715.00 | -1.4% | 0.9% | CN¥2.2t | CN¥2,161.67 | PE27.6x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
INTU | US$661.18 | 4.6% | 48.2% | US$185.1b | US$694.89 | PE66.8x | E17.5% | 0.5% | Software | ||
CB | US$274.28 | 7.6% | 36.3% | US$115.1b | US$268.36 | PE12.4x | E0.7% | 1.3% | Insurance | ||
VRTX | US$445.21 | 5.3% | 30.3% | US$114.9b | US$462.55 | PE28.6x | E10.2% | n/a | Pharmaceuticals & Biotech | ||
1088 | HK$35.85 | -1.8% | 29.9% | HK$831.7b | HK$32.09 | PE11.6x | E2.2% | 6.8% | Energy | ||
REGN | US$982.29 | 0.9% | 29.4% | US$106.0b | US$1,041.52 | PE27.5x | E12.4% | n/a | Pharmaceuticals & Biotech | ||
858 | CN¥156.41 | 1.3% | -8.4% | CN¥607.1b | CN¥191.22 | PE19.1x | E10.7% | 3.0% | Food, Beverage & Tobacco | ||
MRK | €167.20 | 7.5% | 0.5% | €72.7b | €182.31 | PE26.7x | E11.6% | 1.3% | Pharmaceuticals & Biotech | ||
NTES | US$104.97 | 6.5% | 20.1% | US$67.7b | US$133.02 | PE16.6x | E7.8% | 2.4% | Media | ||
MUV2 | €457.80 | 0.5% | 34.8% | €61.2b | €471.64 | PE11.2x | E2.9% | 3.3% | Insurance | ||
8766 | JP¥4,920.00 | -3.8% | 72.0% | JP¥9.7t | JP¥4,704.55 | PE15.5x | E6.0% | 2.5% | Insurance | ||
MRNA | US$132.90 | 13.3% | 5.3% | US$50.9b | US$138.51 | PS9.9x | E68.8% | n/a | Pharmaceuticals & Biotech | ||
PAYX | US$125.65 | 2.5% | 16.2% | US$45.2b | US$120.87 | PE27.2x | E6.3% | 2.8% | Commercial Services | ||
LONN | CHF529.20 | 0.6% | -8.4% | CHF38.2b | CHF576.86 | PE58.4x | E20.7% | 0.8% | Pharmaceuticals & Biotech | ||
DDOG | US$120.07 | 0.9% | 30.4% | US$40.2b | US$146.02 | PE348.4x | E24.1% | n/a | Software | ||
ACGL | US$100.99 | 0.9% | 32.8% | US$37.8b | US$107.40 | PE7.9x | E-11.4% | n/a | Insurance | ||
DB1 | €184.55 | -1.5% | 9.2% | €34.2b | €204.83 | PE19.5x | E5.7% | 2.1% | Diversified Financials | ||
VEEV | US$210.27 | 3.2% | 27.2% | US$34.0b | US$241.82 | PE64.6x | E16.7% | n/a | Healthcare | ||
601225 | CN¥24.40 | -2.2% | 20.2% | CN¥236.6b | CN¥25.71 | PE12.5x | E8.2% | 5.4% | Energy | ||
2020 | HK$89.20 | -3.3% | 3.2% | HK$252.7b | HK$112.73 | PE22.9x | E12.9% | 2.6% | Consumer Durables | ||
KNIN | CHF247.80 | -0.4% | -4.5% | CHF29.3b | CHF244.25 | PE23.5x | E3.3% | 4.0% | Transportation | ||
IFC | CA$229.63 | 0.4% | 12.8% | CA$40.9b | CA$250.13 | PE26.8x | E18.4% | 2.1% | Insurance |